Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in cognitively impaired patients with CADASIL
2004-001162-40Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) comparing Donepezil with Placebo (2 arms). Primary endpoint: V-ADAS-Cog score. Started Dec 2004; status: completed.
02
Drugs
donepezil
03
Conditions
cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
Beyond the preview
Go deeper on 2004-001162-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001162-40.